Als ik hoorde dat mensen GLP-1 wilden proberen, dacht een stemmetje in mijn hoofd al snel: Dat is gewoon een quick fix. Net zoals ik dat eerder dacht bij mensen die voor een maagband kozen
Sharifi-Rad M, Anil Kumar NV, Zucca P, Varoni EM, Dini L, Panzarini E, et al
Norris SL, Lee N, Thakurta S, Chan BKS
This regulatory flexibility allows them to experiment with different production techniques and optimize processes, which can lead to cost savings
Testing both amylase and lipase is generally discouraged because it increases costs while only marginally improving diagnostic efficiency compared to either marker alone. North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Pancreas Committee (NASPGHAN) The NASPGHAN states that the primary biomarkers used to diagnose AP are serum lipase and amylase and note that a serum lipase or amylase level of at least 3 times the upper limit of normal is considered consistent with pancreatitis. Further, NASPGHAN acknowledges that other biomarkers for diagnosis and management of AP have been investigated, but none are prominent and many have yet to be validated for general clinical use. The NASPGHAN defines the diagnosis of AP as Requires at least 2 of the following 1) Abdominal pain not attributable to another cause or suggestive of AP 2) Amylase or lipase 3x the upper limits of normal 3) Imaging consistent with pancreatitis. American Psychiatric Association The American Psychiatric Association published a practice guideline in 2023 for the treatment of patients with eating disorders
